Korea develops oral bacteria-based vaccine mechanism vs Covid-19
이 글자크기로 변경됩니다.
(예시) 가장 빠른 뉴스가 있고 다양한 정보, 쌍방향 소통이 숨쉬는 다음뉴스를 만나보세요. 다음뉴스는 국내외 주요이슈와 실시간 속보, 문화생활 및 다양한 분야의 뉴스를 입체적으로 전달하고 있습니다.
For the vaccine, a well-known salmonella strain was used as a vaccine delivery candidate. Recombinant salmonella cells expressing engineered viral proteins related with Covid-19 pathogenesis were engineered, and the formulation of the oral vaccine candidate strain was evaluated in mice. The vaccine promoted antigen-specific antibody production, and cellular and humoral immunity was induced with no significant toxicity effects, according to the research.
This study is significant in that it has developed a microbial fusion technology for various harmful microorganisms that may appear after the coronavirus pandemic, Dr. Yoon said, hoping that the technology will be utilized as a next-generation vaccine platform applicable to various diseases in the future.
The research findings were published in VACCINES on January 1, 2022 under the title of ‘Development of an Oral Salmonella-Based Vaccine Platform against SARS-CoV-2'. The technology was also filed for patent protection in Korea.
[ⓒ Maeil Business Newspaper & mk.co.kr, All rights reserved]
Copyright © 매일경제 & mk.co.kr. 무단 전재, 재배포 및 AI학습 이용 금지
- Korea develops oral bacteria-based vaccine mechanism vs Covid-19 - Pulse by Maeil Business News Korea
- Maeil Business Newspaper joins as first media validator for health data blockchain - Pulse by Maeil Business News Korea
- Institutions cut off Osstem Implant in funds while authorities move to audit - Pulse by Maeil Business News Korea
- LG Chem, KakaoBank hammered by massive short sale - Pulse by Maeil Business News Korea
- LG Energy Solution mulls adding prismatic type to EV cell lineup - Pulse by Maeil Business News Korea
- 강경준, 상간남 피소…사랑꾼 이미지 타격 [MK픽] - 스타투데이
- AI가 실시간으로 가격도 바꾼다…아마존·우버 성공 뒤엔 ‘다이내믹 프라이싱’
- 서예지, 12월 29일 데뷔 11년 만에 첫 단독 팬미팅 개최 [공식] - MK스포츠
- 이찬원, 이태원 참사에 "노래 못해요" 했다가 봉변 당했다 - 스타투데이
- 양희은·양희경 자매, 오늘(4일) 모친상 - 스타투데이